Work

Clinical trial design of biologic therapies in COPD: MATINEE study of mepolizumab

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa4789

Authors: Ian Pavord, David J. Jackson, Stephanie Korn, Camille Taillé, Karen Miller, Dalal Mouneimne, Jeff Min, Robert Chan, Stefanie Kolterer, Bhabita Mayer, Gerard J. Criner

Institutions: National Institute for Health and Care Research, University of Oxford, Guy's Hospital, King's College London, Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Physiopathologie et Epidémiologie des Maladies Respiratoires, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (Germany), GlaxoSmithKline (United States), Temple University

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404096930

Cites:

Cited by: 1

Related to: 10